More than 7 points means high risk patients to develop peritoneal carcinomatosis. Treatment as HIPEC might prevent it, HIPECT4 trial is waiting for results. Great study from Tsai et al. @ESSOnews @operarelcancer @aecirujanos @EYSAC1 @AndreasBrandl8
A Prediction Model for Metachronous Peritoneal Carcinomatosis in Patients with Stage T4 Colon Cancer after Curative Resection
(1) Background: The aim of this study was to develop a prediction model for assessing individual mPC risk in patients with pT4 colon cancer. Methods: ...
www.mdpi.com
@GarciaOlmoD @Hospital_FJD @VillarejoCampos @h_guadalajara @aecirujanos Enhorabuena @VillarejoCampos !👏
#BCG Unresponsive & unsuitable or unwilling for radical cystectomy?
#HIVEC
“We report a median DFS of 17.7 months potentially avoiding or postponing the need for radical surgery in a proportion of these patients”
#BladderCancer #NMIBC #BladderSparing
Hyperthermic Intravesical Chemotherapy for BCG Unresponsive Non-Muscle Invasive Bladder Cancer Patients - PubMed
HIVEC® seems a valid treatment option for BCG unresponsive NMIBC patients. We report a median DFS of 17.7 months (SE 6.72), potentially avoiding or p...
pubmed.ncbi.nlm.nih.gov
With our partner @MedenInmed at the University Hospital in Fuenlabrada (Madrid); Prof.Murawa and Dr.Cieciorowski watching CRS + PRS HIPEC cases @CombatCancer #HIPEC #PRS
@CombatCancer participará con un stand virtual en el Workshop de GECOP @operaelcancer organizado por el Dr.Fernando Pereira del HU Fuenlabrada los días 10 y 11 de Junio - visítenos y recibirá más información acerca de #HIPEC con la técnica cerrada y agitada PRS+Agitación por CO2
@CombatCancer participará con un stand virtual en el Workshop de GECOP @operaelcancer organizado por el Dr.Fernando Pereira del HU Fuenlabrada los días 10 y 11 de Junio - visítenos y recibirá más información acerca de #HIPEC con la técnica cerrada y agitada PRS+Agitación por CO2
@3speeders @NorthBristolNHS @BladderCancerUK Good luck with your treatment!
#BCGUnresponsive
IBCG - “a clinically meaningful complete response rate for CIS at least 50% at 6m, 30% at 12m..is recommended”
#HIVEC in BCGU
70% CR @ 3m
>50% CR @ 6m
STILL 50% CR @ 12m
https://tinyurl.com/5arewevc
#BladderCancer
#BladderCancerAwarenessMonth
Definitions, End Points, and Clinical Trial Designs for Non–Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer Group
To provide recommendations on appropriate clinical trial designs in non–muscle-invasive bladder cancer (NMIBC) based on current literature and exper...
tinyurl.com
🇵🇱First successful Combat PRS+A-HIPEC Cases after CRS done at the Lower Silesian Oncology Institute in Wroclaw last week🇵🇱 with our local partner Meden-Inmed Sp. z o.o.!
Many thanks to Prof.Dr.Bebenek and his team for the opportunity.@CombatCancer @ESSOnews @operarelcancer #HIPEC
Great results from our friends @DukeUrology on the use of HIVEC in the USA.
“HIVEC is a safe and well-tolerated substitute for BCG during global shortages”
👏🏻👏🏻👏🏻 @DominicGrimberg @BrantInman
#BladderCancer #Cancer #HIVEC
https://www.sciencedirect.com/science/article/abs/pii/S1078143920306542
Intravesical hyperthermia with high-dose mitomycin-C shows promise as BCG alternative for NMIBC
"Our study demonstrates the feasibility of HIVEC MMC and suggests it is a reasonable substitute for BCG during global shortages," says urologist Scott...
www.urologytimes.com
Great results from our friends @DukeUrology on the use of HIVEC in the USA.
“HIVEC is a safe and well-tolerated substitute for BCG during global shortages”
👏🏻👏🏻👏🏻 @DominicGrimberg @BrantInman
#BladderCancer #Cancer #HIVEC
https://www.sciencedirect.com/science/article/abs/pii/S1078143920306542
Intravesical hyperthermia with high-dose mitomycin-C shows promise as BCG alternative for NMIBC
"Our study demonstrates the feasibility of HIVEC MMC and suggests it is a reasonable substitute for BCG during global shortages," says urologist Scott...
www.urologytimes.com
More great news for Combat’s #HIVEC treatment of #bladdercancer from @BrantInman and team at @ASCO meeting.
“Bladder pressure dramatically improves the extent of gemcitabine penetration into the bladder wall”
https://meetinglibrary.asco.org/record/194854/abstract
Many thanks to the team @DukeUrology 👏🏻👏🏻👏🏻
Excellent to hear this. So happy our machine is working to treat patients in Bristol. @CombatCancer #HIVEC #bladdercancer @NorthBristolNHS
Here I go again, this treatment is amazing and I’m so grateful to @NorthBristolNHS #urology for providing this ‘maintenance’ #bladdercancer @CombatCancer @Actionbladderca
Here I go again, this treatment is amazing and I’m so grateful to @NorthBristolNHS #urology for providing this ‘maintenance’ #bladdercancer @CombatCancer @Actionbladderca
@alarjosan @HUReinaSofia @IMIBIC @GECOP_ @operarelcancer @SPeritoneum @aecirujanos @ESSOnews @Hospital_FJD Congrats @alarjosan and team!
Proud to be working with you!
👏🏻👏🏻👏🏻👏🏻👏🏻
There are some great posters @ #BLADDR18 #HIVEC pic.twitter.com/bDnahheB4s
— Combat Medical #HIVEC #HIPEC (@CombatCancer) September 20, 2018
